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Cellular iron metabolism. Iron is essential for oxidation-reduc- involved in energy metabolism (mitochondrial aconitase
tion catalysis and bioenergetics, but unless appropriately and [Fe-S] proteins of the electron transport chain) and
shielded, iron plays a key role in the formation of toxic oxygen
DNA synthesis (ribonucleotide reductase). Moreover,radicals that can attack all biological molecules. Hence, special-
iron-containing proteins are required for the metabolismized molecules for the acquisition, transport (transferrin), and
storage (ferritin) of iron in a soluble nontoxic form have of collagen, tyrosine, and catecholamines. On the other
evolved. Delivery of iron to most cells, probably including hand, chemical properties of iron that are so useful forthose of the kidney, occurs following the binding of transferrin
an astonishing array of biological functions have createdto transferrin receptors on the cell membrane. The transferrin-
receptor complexes are then internalized by endocytosis, and problems for living organisms. In solution, iron exists in
iron is released from transferrin by a process involving endoso- two oxidation states, Fe(II) and Fe(III), which can do-
mal acidification. Cellular iron storage and uptake are coordi-
nate or accept electrons, respectively. However, thesenately regulated post-transcriptionally by cytoplasmic factors,
redox reactions may become hazardous for the organism.iron-regulatory proteins 1 and 2 (IRP-1 and IRP-2). Under
conditions of limited iron supply, IRP binding to iron-respon- At physiological pH and oxygen tension, Fe(II) is readily
sive elements (present in 59 untranslated region of ferritin oxidized to Fe(III), which rapidly forms essentially insol-
mRNA and 39 untranslated region of transferrin receptor
uble Fe(OH)3 polymers. Moreover, unless appropriatelymRNA) blocks ferritin mRNA translation and stabilizes trans-
ferrin receptor mRNA. The opposite scenario develops when chelated, iron, because of its catalytic action in one-
iron in the transit pool is plentiful. Moreover, IRP activities/ electron redox reactions, plays a key role in the forma-
levels can be affected by various forms of “oxidative stress” tion of harmful oxygen radicals that ultimately causeand nitric oxide. The kidney also requires iron for metabolic
peroxidative damage to vital cell structures [5, 6]. Thus,processes, and it is likely that iron deficiency or excess can
cause disturbed function of kidney cells. Transferrin receptors organisms were compelled to solve one of the many
are not evenly distributed throughout the kidney, and there paradoxes of life, that is, to keep “free iron” at the lowest
is a cortical-to-medullary gradient in heme biosynthesis, with
possible level and yet in concentrations allowing its ade-greatest activity in the cortex and least in the medulla. This
quate supply for the synthesis of hemoproteins and othersuggests that there are unique iron/heme metabolism features
in some kidney cells, but the specific aspects of iron and heme iron-containing molecules. This has been achieved by
metabolism in the kidney are yet to be explained. the evolution of specialized molecules for the acquisition,
transport, and storage of iron in a soluble, nontoxic form
to meet cellular and organismal iron requirements. More-Iron represents a paradox for living systems by being
over, organisms are equipped with highly sophisticatedessential for a wide variety of metabolic processes, but
mechanisms that coordinately regulate cellular iron up-also having the potential to cause deleterious effects
take and storage and maintain iron in the intracellular[1–5]. On the one hand, iron is indispensable for life,
labile pool at appropriate levels.serving as metal cofactor for many enzymes, either non-
The kidney, like other organs, requires iron for meta-heme iron-containing proteins or hemoproteins. Hemo-
bolic processes, and it is likely that iron deficiency orproteins are involved in a broad spectrum of crucial
biologic functions, including oxygen binding (hemoglo- excess can cause disturbed function of kidney cells. Al-
bins), oxygen metabolism (oxidases, peroxidase, cata- though little information is available on iron metabolism
lases, etc.), and electron transfer (cytochromes). Many in kidney cells, they probably acquire most of their iron
nonheme iron-containing proteins catalyze key reactions from plasma glycoprotein, transferrin. This review pro-
vides an overview of the molecular mechanisms involved
in cellular iron uptake and metabolism, and an attemptKey words: iron metabolism, heme biosynthesis, transferrin, toxic oxy-
gen radicals, endosomal acidification, oxidative stress. is made to identify and discuss some specific aspects of
iron and heme metabolism in the kidney. 1999 by the International Society of Nephrology
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PROTEINS INVOLVED IN IRON TRANSPORT the ferroxidase activity of ceruloplasmin. It is conceiv-
able that ceruloplasmin may facilitate cellular iron releaseAND STORAGE
by promoting the oxidation of Fe(II), the redox form inTransferrin
which iron appears to be within the intracellular “transit”
Physiologically, the majority of cells in the organism pool [12]. In this regard, it may be pertinent to mention
acquire iron from a well-characterized plasma glycopro- that the yeast Saccharomyces cerevisiae possesses a mem-
tein, transferrin (approximately 80 kD) [2, 4]. Transferrin brane-spanning ferroxidase (Fet3) that has homology to
consists of two homologous domains, each of which con- the multicopper oxidases, including ceruloplasmin, and
tains one high-affinity Fe(III)-binding site. Affinity of that is required for high-affinity iron transport [13].
iron to transferrin is a pH-dependent process. In plasma Normally, plasma iron concentration is approximately
(pH approximately 7.4), transferrin binds iron very 18 mmol/liter, and total iron-binding capacity (a measure
strongly (Kd approximately 10223 mol/liter), whereas vir- of plasma transferrin levels) is approximately 56 mmol/
tually no binding occurs at pH # 4.5, and this property liter; thus, transferrin is about one-third saturated with
plays an important role in the physiological mechanism iron, with approximately 10% present as a diferric trans-
of iron release from transferrin (detailed later in this ferrin. In healthy adults, the total plasma iron pool (ap-
article). Transferrin binds iron via the phenolate oxygens proximately 3 mg) remains remarkably constant despite
of two tyrosine residues, an imidazole nitrogen of a histi- being turned over more than 10-fold every day and is
dine residue and a carboxylate oxygen of an aspartic virtually unaffected by iron in stores (ferritin and hemo-
acid residue [7]. These protein ligands occupy four of siderin) that can vary from 350 to 900 mg in females
the six octahedral sites around each iron atom, leaving and males, respectively [14]. Hence, there seems to be
two cis positions to be filled by the anion carbonate (or a control mechanism that guarantees that the rate of
bicarbonate). Binding and release of iron by transferrin iron release from stores perfectly matches the one with
are accompanied by dramatic conformational changes which the iron is taken up by tissues, but the nature of
in the protein. In the absence of iron, the two domains this regulation is unknown. Hemodialysis patients with
involved in the binding are widely separated and assume normal or even increased iron in stores sometimes de-
an “open” configuration. On the other hand, insertion velop resistance to erythropoietin therapy [15]. This con-
of iron brings two domains of the binding cleft close dition is referred to as “functional iron deficiency” and
toward the metal, and transferrin assumes “closed” con- is caused by an inadequate mobilization of ferritin iron
formational state [8]. during rapid hemoglobin regeneration.
Transferrin functions to transport iron between sites In patients with severe iron overload, plasma can con-
of absorption, storage, and use. Although the transferrin- tain transferrin completely saturated with iron and also
to-cell branch of the metabolic iron cycle is reasonably a chelatable low molecular weight iron fraction not asso-
well known (discussed later in this article), the mecha- ciated with transferrin [16]. Nonspecific, non-transferrin–
nism and regulation of iron mobilization and transport bound iron is rapidly cleared from the plasma, mainly
from tissue stores to plasma transferrin are the least by the liver [17]. However, there is also evidence for
understood aspects of iron metabolism. Transferrin re- the occurrence of a non-transferrin–bound iron uptake
ceives most of its iron from hemoglobin catabolized by system in renal cortex [18].
macrophages of the reticuloendothelial system (for ex- Although transferrin can be synthesized by many tis-
ample, Kupffer cells). Senescent erythrocytes are inter- sues, including lymph nodes and circulating lymphocytes,
nalized by the macrophages that liberate iron from its macrophages, bone marrow, spleen, thymus, salivary
confinement within the protoporphyrin ring by the action glands, mammary glands, and Sertoli cells of testis, the
of heme oxygenase [9, 10] and then release iron almost liver is the major source of plasma transferrin in adults
quantitatively to transferrin in the circulation. Unfortu- [2, 19]. In mouse or rat fetuses, transferrin mRNA can
nately, the mechanisms and controls involved in the re- be detected in kidney, and its content increases during
lease of iron from macrophages and other cells have fetal development up to birth and then rapidly decreases
not been defined. Interestingly, studies of patients with [20]. Hence, it is likely that transferrin is synthesized in
recently identified genetic deficiency of ceruloplasmin fetal kidney, and it is tempting to speculate that it serves
suggest that iron may be released from cells of many an important local function in providing iron for the
tissues, and not just the liver and macrophages as once growth and metabolism of cells during kidney develop-
thought. Ceruloplasmin is a blue copper-containing pro- ment. The liver and kidneys account for approximately
tein with ferroxidase activity, and patients with heredi- 50% of the total rate of transferrin catabolism. Catabo-
tary aceruloplasminemia have low plasma iron levels, lism of transferrin in the liver is probably the result of
but marked iron accumulation is evident in the liver, endocytotic uptake and lysosomal degradation, whereas
pancreas, brain, and also the kidney [11]. One possible that in the kidney is probably due to glomerular filtration
explanation of iron overload in aceruloplasminemic pa- followed by reabsorption and degradation by the renal
tubules [21].tients is that the release of iron from the cells requires
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Transferrin receptors Ferritin
Ferritin is a ubiquitous protein in which the onlyTransferrin is recognized by specific cell membrane
clearly defined function is the sequestration and storagereceptors that are gatekeepers responsible for physiolog-
of iron [2, 23]. Mammalian ferritin consists of a proteinical iron acquisition by most cell types in the organism
shell that can accommodate up to 4,500 atoms of iron[2]. The transferrin receptor consists of a disulfide-linked
in its internal cavity. The molecular structure of horsetransmembrane glycoprotein homodimer having a mo-
spleen ferritin has been well characterized. The proteinlecular radius (Mr) of 180 kDa, and each subunit (90 kDa)
shell by itself has a molecular mass between 430 and 460binds one molecule of transferrin. The human transferrin
kDa, is approximately 25 A˚ thick, and is made up ofreceptor contains a small N-terminal cytoplasmic domain
24 symmetrically related subunits of two types, a lightof hydrophilic character having a molecular mass of 5
subunit (L-subunit) of approximately 19 kDa and akDa and frequently contains a phosphate group bound
heavy subunit (H-subunit) of approximately 21 kDa. Theto the hydroxyl moiety of serine-24. However, the phos-
amino acid sequences of the H- and L-subunits differ byphorylation and dephosphorylation of this latter residue
approximately 50%, and the ferritin genes from severalis not required for controlling endocytosis or recycling
species, including humans, have been cloned and se-of the transferrin receptor. The cytoplasmic domain of
quenced [23]. Different proportions of the two subunits
the transferrin receptor is essential for receptor internal-
give rise to the heterogeneity of ferritin observed in
ization, and a tetrapeptide sequence within the cyto- different tissues. The ferritin molecule has an internal
plasmic tail of the transferrin receptor acts as a signal diameter of 70 to 80 A˚ and an external diameter of 120
for high-efficiency endocytosis. The cytoplasmic tail is to 130 A˚. The entry and exit of iron may occur via
linked to a C-terminal extracellular domain of 672 amino channels in the protein shell. There are six fourfold chan-
acids by a hydrophobic membrane-spanning segment 62 nels that are hydrophobic in nature and eight threefold
amino acids from the N-terminus, and this hydrophobic channels that are hydrophilic, and all of these channels
part of the transferrin receptor contains covalently bound are approximately 3 to 4 A˚ in diameter [23]. Once within
fatty acid residues (palmitic acid) as a result of post- the protein shell, iron is stored in the ferric state as ferric-
translational modification [2]. In nonerythroid cells, trans- oxyhydroxide phosphate of approximate composition
ferrin receptor numbers correlate negatively with iron (FeOOH)8 (FeO-OPO3H2), and as described earlier
levels in an ill-defined “transit iron pool,” and the regula- here, holoferritin can accommodate approximately 4500
tion of the receptor synthesis is post-transcriptional and atoms of iron, doubling its molecular mass to 900 kDa.
involves modulation of transferrin receptor mRNA sta- Iron exchange with ferritin has been extensively stud-
ied in vitro. There is a consensus that relatively solublebility (see later here). However, in erythroid cells, the
ferrous iron, which is incorporated into the shell muchprimary control of transferrin receptor expression ap-
more efficiently than ferric iron, is oxidized and depos-pears to be transcriptional, and the transcription proba-
ited after its association with the inner surface of thebly plays an important role in maintaining high levels of
subunits. Recombinant H-ferritin, as compared with re-receptor needed to support hemoglobinization [3].
combinant L-chain, incorporates iron at rates severalThe reported association constants of transferrin for
times greater, and this difference is likely caused by athe receptor vary greatly (1027 to 1029 mol/liter), proba-
ferroxidase center associated with the H-ferritin subunitbly depending on conditions of measurement and cells
that promotes the oxidation of Fe(II) to Fe(III). On theused. The iron status of transferrin has an important
other hand, L-chain apoferritin has a higher capacityeffect on the affinity of transferrin for its receptor, with
than the H-subunit to induce iron-core nucleation [23].diferric transferrin having the greatest affinity, monofer-
Unfortunately, we know virtually nothing about the ex-ric transferrins an intermediate affinity, and apotransfer-
change of iron with ferritin in intact cells, and some
rin very low affinity [22]. As already mentioned, normal evidence indicates that the degradation of the ferritin
plasma transferrin concentration is approximately 50 protein may be an important mechanism for the release
mmol/liter, of which diferric transferrin constitutes ap- of iron within the cell [24].
proximately 10%. Because the association constant of Ferritin synthesis is inducible by iron by a mechanism
diferric transferrin is 30- and 500-fold higher than those in which iron recruits ferritin mRNA from an inactive
of monoferric and apotransferrin, respectively [22], the pool (discussed later in this article). In addition, inflam-
delivery of iron to cells is predominantly by diferric trans- matory cytokines and “oxidative stress” are involved in
ferrin. The concentration of diferric transferrin in normal an iron-independent regulation of ferritin translation,
plasma is adequate for saturating all cellular transferrin and transcriptional regulation of ferritin gene expression
receptors with the ligand. The structural features of has been described [4].
transferrin that are required for the interaction of trans- Although the only well-defined function of ferritin is
the storage and detoxification of intracellular nonfunc-ferrin with the receptor have not yet been established.
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Fig. 1. Schematic representation of iron up-
take from transferrin via receptor-mediated en-
docytosis in mammalian cells. Extracellular dif-
erric transferrin (Tf) is bound by the membrane-
bound Tf receptor and internalized via receptor-
mediated endocytosis into an endosome. Iron
is released from Tf, probably by a decrease in
pH, and is then transported through the mem-
brane by an uncharacterized transporter. A pos-
sible candidate for endosomal iron transporter
is natural resistance-associated macrophage
protein-2 (Nramp2) [28–30]. Once the iron has
passed through the membrane, it then enters a
very poorly characterized compartment known
as the intracellular labile iron pool. Apotransf-
errin remains bound to the transferrin receptor
and is then released by exocytosis. Iron that
enters the cell can be used for metabolic func-
tioning or can be stored in ferritin. It is thought
that iron in the intracellular iron pool modulates
the activity of iron regulatory proteins 1 and 2
(IRP-1 and IRP-2) (Adapted from [2]; used with
permission).
tioning iron, it is known that small amounts of ferritin Moreover, it has been suggested that the serum ferritin
are present in the plasma. Ferritin was detected in the may not be the product of the same genes as those encod-
circulation of normal subjects about 25 years ago, but the ing intracellular ferritin [25].
origin and possible physiological role of plasma ferritin in
normal individuals remain elusive. However, it is known
CELLULAR IRON ACQUISITIONthat normal serum ferritin, in contrast to cellular ferritin,
FROM TRANSFERRINis partly glycosylated, suggesting that it is synthesized by
The current view on iron acquisition via transferrin-the rough endoplasmic reticulum. It is generally believed
receptor–mediated endocytosis, which is likely to bethat plasma ferritin has a low iron content, even in iron-
identical in all cell types, is schematically depicted inoverloaded individuals [14], and further support for this
Figure 1 [2–4, 19]. In the first step, transferrin attacheswas recently provided by Linder et al. These latter inves-
to specific receptors on the cell surface by a physicochem-tigators have identified a number of other unexpected
ical interaction, not requiring temperature and energy.differences between plasma and tissue ferritin, sug-
gesting the distinct nature of ferritin in the circulation. By a temperature- and energy-dependent process, the
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transferrin-receptor complexes are then internalized by that although the non-receptor–mediated iron uptake
from transferrin, occurring after the saturation of recep-the cells enclosed within endocytic vesicles. Iron is re-
tors, is far greater than the iron uptake via the receptorleased from the transferrin within the endocytic vesicles
pathway, very little is known about the mechanism ofby a temperature- and energy-dependent process that
iron acquisition. It is not known whether this uptakeinvolves endosomal acidification [26]. An influx of pro-
system is present in some cells of the kidney.tons into endosomes probably occurs via an adenosine
triphosphate-dependent H1 pump that is, however, poorly
defined. The minimum pH in endosomes (approximately REGULATION OF IRON LEVELS IN THE
5.3) is not low enough to remove iron from both Fe- INTRACELLULAR LABILE POOL
binding sites of transferrin, yet cells are capable of re-
Iron, following its release from transferrin within en-moving iron from transferrin with remarkable efficacy.
dosomes, likely enters the labile intermediate pool fromThis paradox has recently been explained by document-
which it is available for intracellular use or for storageing that binding to cellular receptors promotes more
in ferritin and in some cells for return to extracellularefficient iron release from transferrin at mildly acidic pH
apotransferrin. Another source of iron for this pool[27]. Iron transport across the endosomal membrane is
comes from the breakdown of non-heme–containing andpoorly characterized and likely requires a specific trans-
heme–iron–containing proteins. It has been proposedporter. One candidate for endosomal iron transporter
that iron in this pool may be complexed to citrate, sugars,
is “natural resistance-associated macrophage protein-2,” some amino acids, pyridoxal, and nucleotides, but the
the mutation of which is a likely cause of decreased iron real chemical nature of this metabolically and kinetically
uptake by erythroid cells (and possibly other cells) of active pool remains elusive [2]. The only abiding cer-
mice with microcytic anemia (mk/mk) [28] and of anemic tainty seems to be that this iron is accessible to strong
Belgrade (b/b) rats [29]. Interestingly, natural resistance- chelators. Sensitive control mechanisms that monitor
associated macrophage protein-2 appears to be involved iron levels in the labile pool and that prevent the expan-
in intestinal iron transport as well [28, 30], and further sion of this pool (to combat Fenton chemistry), while
research is needed to determine its precise cellular local- still making the metal available for iron-dependent pro-
ization in various cell types. Iron, probably complexed teins and enzymes, have developed during evolution. In
with an as yet unidentified ligand, is then transported to general, enlargement of the intracellular transit iron pool
intracellular sites of use and/or storage in ferritin. This leads not only to a stimulation of ferritin synthesis, but
aspect of iron metabolism, including the nature of the also to a decrease in the expression of transferrin recep-
elusive intermediary pool of iron and its cellular traffick- tors. The opposite scenario develops when this pool is
ing, remains enigmatic. Only in erythroid cells does some depleted of iron. Interestingly, a single genetic regulation
evidence exist for a specific targeting of iron toward mito- system is responsible for these changes in expression of
chondria [2, 3, 31], which are sites of heme production structurally unrelated proteins, ferritin, and transferrin
by ferrochelatase, an enzyme inserting iron into proto- receptors.
porphyrin IX. Recent studies with erythroid cells showed Research conducted on nonerythroid cells cultured in
that the inhibitors of the microfilament motor, myosin, vitro revealed that iron-dependent regulation of both ferri-
inhibited 59Fe incorporation from 59Fe-transferrin–labeled tin and transferrin receptors occurs post-transcriptionally
endosomes into heme [32]. These observations, together and is mediated by virtually identical iron-responsive
with confocal microscopy studies exploiting transferrin elements (IREs). IREs were first identified in the 59
and mitochondria labeled by two distinct fluorescent la- untranslated regions (UTRs) of ferritin H- and L-chain
bels [32], suggest that in erythroid cells, a transient mito- mRNAs [2–4, 33–37] and were documented to mediate
chondria–endosome interaction is involved in iron trans- inhibition of ferritin mRNA translation in iron-deprived
location to mitochondrial ferrochelatase. The iron-free cells. Five similar IRE motifs (contrary to single IRE in
apotransferrin, which remains attached to the receptor ferritin mRNAs) were later identified within the 2.7 kb 39
at pH approximately 5.5, returns to the cell surface where UTR of transferrin receptor mRNA. These IREs confer
the apotransferrin is released from the cells, available differential stability to transferrin receptor mRNAs as
for acquiring iron from macrophages and to a lesser a function of cellular iron levels. The IRE is also present
extent from hepatocytes, gut, and other cells. in the 59 UTR of mRNA for erythroid-specific 5-amino-
Some cells cultured in vitro possess not only specific levulinic acid synthase (ALA-S2; the first enzyme of
saturable receptor-mediated iron uptake, but also non- heme biosynthesis), the expression of which in hemoglo-
saturable, nonspecific uptake [2]. Although it was origi- bin-synthesizing cells depends on the availability of iron
nally suggested that during this process iron was released [3]. The IREs are cis-acting nucleotide sequences, form-
from transferrin at the cell surface, more recent studies ing a stem-loop structure, that contain an unpaired cyti-
indicate that after saturation of the transferrin receptors, dine six bases 59 of a six-membered loop, the sequence
iron is acquired from transferrin taken up by the cells of which is CAGUGN. These hairpin structures are rec-
ognized by trans-acting cytosolic RNA-binding proteinsvia low-affinity adsorptive pinocytosis. It is intriguing
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Fig. 2. Role of iron regulatory protein (IRP)-
1 in the regulation of ferritin mRNA translation
and transferrin receptor mRNA stability. In
contrast to IRP-1, regulation of IRP-2 (not
shown) by iron is mediated by specific proteoly-
sis. Details are in the text. Reprinted with per-
mission from Ponka et al [4].
known as iron-regulatory proteins (IRPs, formerly known Although the IRE/IRP system is tailored to sense the
as IRE-binding proteins, iron regulatory factor, or ferri- “iron-in-transit” and maintain it at appropriate levels,
tin repressor protein). iron is not the only player that modulates IRP-1 activity.
Two closely related IRPs, designated IRP-1 and IRP-2, Nitric oxide (NO) is an important endogenous regulator,
have been purified and cloned from a variety of mamma- many of whose actions are mediated via binding of NO
lian tissues and cells [2, 35, 37]. IRP-1 shares homology to iron in the heme of guanylate cyclase or in the [Fe-S]
with mitochondrial aconitase, a [4Fe-4S] cluster-con- centers of important nonheme iron proteins [2]. Al-
taining enzyme of the citric acid cycle. In iron-replete though iron interacts primarily with NO
.
(free radical),
cells, IRP-1 also contains a [4Fe-S] cluster and, in this its oxidized form, NO1 (nitrosonium ion) causes S-nitro-
form, possesses aconitase activity and binds RNA with sylation of SH-groups of proteins [38]. NO is well known
low affinity. In contrast, when iron is scarce, IRP-1 lacks to modulate the activity of mitochondrial aconitase,
a [4Fe-4S] cluster and aconitase activity and binds to IREs which, as already mentioned, is highly homologous to the
with high affinity. The transition between the aconitase IRP-1. Recent studies in the author’s laboratory revealed
and RNA-binding form of IRP-1 occurs without changes that although NO
.
increases IRP-1 binding activity,
in IRP-1 protein levels. IRP-2 shares 61% overall amino transferrin receptor mRNA, and transferrin receptor
acid identity with IRP-1, binds to IREs with similar affin- numbers, NO1 decreases IRP-1 activity, transferrin re-
ities as IRP-1, and on binding represses translation of ceptor mRNA, and transferrin binding in K562 cells [39].
IRE-containing mRNAs. However, in contrast to IRP-1, It was concluded that NO1 may cause S-nitrosylation of
IRP-2 functions solely as an RNA-binding protein be- critical thiol groups, which may prevent the binding of
cause it lacks aconitase activity, and regulation of IRP-2
IRP-1 to the IRE, a condition known to prevent trans-by iron is mediated by specific proteolysis [2, 35, 37].
ferrin receptor mRNA degradation. On the other hand,Research in numerous laboratories has revealed that
NO
.
may directly react with the [Fe-S] cluster that maythe interactions of IRPs with IREs control iron metabo-
be followed by a loss of the cluster [37, 39], resulting inlism in nonerythroid cells in the following manner (Fig. 2):
an increase in the binding of IRP-1 to IRE, a conditionWhen cellular iron becomes limiting, the IRP-1 is re-
known to stabilize transferrin receptor mRNA. Othercruited into the high-affinity binding state. The binding
studies have shown that the increase in endogenous NOof IRP-1 to the IRE in the 59 UTR of the ferritin mRNA
enhances the binding of IRP-1 to IREs and inhibits ferri-represses the translation of ferritin, whereas an associa-
tin synthesis [37]. Moreover, treatment of cell culturestion of IRP-1 with IREs in the 39 UTR of transferrin
with H2O2 causes the rapid stimulation of the RNA-receptor mRNA stabilizes this transcript against as yet
binding activity of IRP-1, leading to decreased ferritinundefined ribonucleases. On the other hand, the expan-
synthesis [37]. Collectively, these results indicate thatsion of the labile iron pool inactivates IRP-1 and leads
NO and “oxidative stress” can dramatically affect cellu-to a degradation of IRP-2, resulting in an efficient trans-
lar iron metabolism.lation of ferritin mRNA and rapid degradation of trans-
ferrin receptor mRNA [2, 35, 37]. Some specialized cells with specific iron/heme metabo-
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lism characteristics probably evolved additional regula- canine kidney cells [46]. Interestingly, transferrin recep-
tory mechanisms that can override the “ubiquitous” IRE/ tors in the kidney show uneven distribution, the highest
IRP control system. As already mentioned, in erythroid levels of expression being in the convoluted parts of the
cells, transferrin receptor expression is regulated tran- distal tubules in the kidney cortex and in collecting ducts
scriptionally [3]. In macrophages (one of the functions of the kidney medulla [47]. As already discussed, utiliza-
of which is to catabolize large quantities of hemoglobin), tion of mRNAs containing IREs (transferrin receptor,
iron increases, rather than decreases, transferrin mRNA ferritin) is modulated by iron-regulated RNA-binding
and protein levels [40], probably because of a surprising proteins. Both IRP-1 and IRP-2 are present in kidney
activation of IRP-1 [41]. cytosol [48], and hence, it is likely that they play at least
some role in the expression of transferrin receptors and
ferritin in the kidney. However, mechanisms responsibleIS THERE A DISTINCT IRON/HEME
for variations in transferrin receptor expressions in dif-METABOLISM IN THE KIDNEY?
ferent parts of the kidney are not known.Information on iron metabolism and heme biosynthe-
Feeding rats with a diet containing high iron for 15 orsis in nonerythroid and nonhepatic tissues is far less than
63 days leads to a significant increase in nonheme ironadequate, and these aspects are poorly understood even
levels in the kidney [49], and patients with iron overloadin the kidney, which has very active oxidative phosphory-
(such as b-thalassemia/hemoglobin E disease), as com-lation that depends on numerous heme as well as non-
pared with normal subjects, show an approximatelyheme iron-containing proteins. Compared with other or-
threefold increase in kidney iron concentration [50].gans, the kidney is characterized by unusual features
However, the iron concentration is approximately 10with respect to oxygen consumption that indicates the
times higher in the liver and 45 times higher in the pan-importance of mitochondrial activity in this organ. A
creas from the thalassemic patients than in those of non-remarkably high content of mitochondria is found in
certain nephron segments: proximal convoluted tubule, thalassemic individuals, suggesting a control mechanism
proximal straight tubule, and the thick ascending limbs that prevents a conspicuous loading of the kidney tissue
of Henle’s loop [42]. This is not surprising because these with iron. Nevertheless, iron overload results in in-
kidney regions are involved in active transport requiring creased urinary levels of the lysosomal enzyme, N-acetyl-
the generation of energy in the form of adenosine tri- b-D-glucosaminidase, which is regarded as an early mark-
phosphate formed within mitochondria by the process er of kidney damage [51]. Moreover, iron-overloaded
of oxidative phosphorylation. In addition, the kidney patients excrete significantly more urinary protein and
contains numerous nonmitochondrial hemoproteins that b2-microglobulin and have increased levels of plasma
play important metabolic or regulatory functions such and urine malonyldialdehyde levels [52]. It is likely that
as cytochrome P450, catalase, cyclooxygenase, guanylate in iron-overloaded patients, redox-active iron catalyzes
cyclase, and NO synthase, just to name a few. One hemo- the formation of free radicals and active oxygen species
protein, although still putative, deserves to be singled that can cause renal cell injuries. Importantly, iron may
out. In the normal person, the kidney is the principal play a role in the tubulointerstitial injury in conditions
source of erythropoietin that is essential for erythroid not associated with iron overload. Iron accumulation in
differentiation and consequently the formation of hemo- tubular cell lysosomes was shown in patients with chronic
globin-containing erythrocytes. Erythropoietin produc-
renal disease [53], as well as in several models of renal
tion is controlled by oxygen, and hypoxia is well known
disease [54], including partial nephrectomy and adriamy-to cause marked increase in erythropoietin formation.
cin nephrotoxicity. It has also been proposed that ironBunn et al [43] proposed and provided compelling evi-
and oxygen radicals may play a key role in the progres-dence that the oxygen sensor involved in the control of
sion of chronic renal failure [55]. Proteinuria, resultingerythropoietin production is a heme protein [43, 44], the
from the glomerular injury, may perpetuate renal injury,identity of which, however, has yet to be established.
and it has generally been assumed that the tubulointersti-
tial injury is induced by albumin. However, Alfrey re-Iron metabolism
cently pointed out that iron-containing transferrin, whichIt is likely that the major source of iron for kidney cells
can be excreted during glomerular disease, may play anis plasma transferrin. Research conducted on polarized
important pathogenetic role [55]. As described earlierMadin-Darby canine kidney cells revealed that trans-
here, at a pH of approximately 7.4, transferrin binds ironferrin receptor is selectively delivered to the basolateral
extremely tightly, but at the reduced pH of tubule fluid,surface, where it internalizes transferrin via clathrin-
iron is likely to dissociate from transferrin and catalyzecoated pits and recycles back to the basolateral border
the formation of free radicals that cause tubulointerstitial[45]. Recent studies suggest that calmodulin may be in-
volved in the recycling of transferrin in Madin-Darby injury [55].
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Heme metabolism bilirubin, may have antioxidant properties [60]. Recently,
Poss and Tonegawa convincingly documented that hemeHeme biosynthesis involves eight enzymes, four of
ogygenase-1 serves as an adaptive mechanism to protectwhich are cytoplasmic and four of which are localized
cells from oxidative damage during the stress. These in-in the mitochondria. As compared with nonerythroid
vestigators generated heme-oxygenase-1–deficient micecells, erythroid cells show intriguing differences in sev-
[61] and showed that these animals, as well as cells de-eral heme pathway enzymes at gene [ALA-S1 (ubiqui-
rived from them, were highly susceptible to the accumu-tous) and ALA-S2 (erythroid-specific)], mRNA (ALA
lation of free radicals and to oxidative injury [62]. More-dehydratase and porphobilinogen deaminase), and pro-
over, they showed that heme oxygenase-1–deficient micetein levels [3]. It is likely that heme pathway enzymes
developed an anemia with abnormally low plasma ironin the kidney are identical to those expressed in other
[61]. These findings indicate that heme oxygenase-1, innonerythroid cells and that all the enzymes beyond por-
contrast to heme oxygenase-2, in which deficiency is notphobilinogen deaminase step are, in fact, the same in all
associated with disturbances in iron metabolism, plays acells in the organism. For example, ferrochelatase, an
key role in recycling hemoglobin iron. Furthermore,enzyme inserting iron into protoporphyrin IX to form
heme oxygenase-1–deficient mice developed conspicu-heme, appears to be identical in kidney, liver, and ery-
throid cells [56]. Interestingly, the overall capacity for ous nonheme iron-loading in the liver, kidney, and other
heme biosynthesis is not evenly distributed throughout cells [61]. This latter observation is unexpected and sug-
all cells of the kidney. There is a cortical-to-medullary gests a link between iron release from the cells, including
gradient in heme biosynthesis, with greatest activity in those of the kidney, and heme oxygenase-1 activity.
the cortex and least in the medulla. Within the cortex, In summary, although our knowledge on iron and
the capacity to synthesize heme is primarily associated heme metabolism in the kidney is incomplete and rather
with the proximal tubule cells [57]. There are dramatic fragmented, it appears that at least some cells in the
differences in the regulation of heme synthesis in ery- kidney have specific features in regard to the previously
throid versus nonerythroid cells (such as liver) [3], and mentioned metabolic parameters. This conclusion is sup-
as expected, the regulation of heme biosynthesis in the ported by findings that certain areas of the kidney are
kidney is qualitatively comparable with that observed in remarkably rich in mitochondria, an organelle ultimately
the liver. However, porphyrinogenic chemicals induce related to iron and heme metabolism. Moreover, the
ALA synthase more slowly in the kidney than in the presence of the high heme biosynthetic capacity within
liver [57]. This relative refractoriness of renal ALA syn- the cells of the proximal tubule suggests that unique
thase to induction is probably caused by a greater ratio of control mechanisms exist allowing high rates of heme
uncommitted (“free” regulatory) heme to overall heme synthesis in the cortex. Furthermore, the uneven distri-
biosynthetic activity in renal cells, as compared with the bution of transferrin receptor and heme biosynthetic ca-
hepatocyte [57].
pacity in the kidney indicates unique iron metabolismHeme oxygenase, which catabolizes heme to biliver-
characteristics in certain areas of the kidney. Obviously,din, carbon monoxide, and iron, is responsible for degra-
much further work is needed to define and more com-dation of heme in kidney cells as in virtually all the cells
pletely explain the nature of these distinct iron/hemein the organism (with the exception of mature erythro-
metabolism features.cytes and some other highly differentiated cells). Heme
oxygenase is represented by two isoforms (1 and 2) that
are encoded by two separate genes. Heme oxygenase-2 NOTE ADDED IN PROOF
is constitutively expressed, and it is possible that carbon
Recently, kidney has been shown [Canonne-Ergauxmonoxide generated by this isoform is a physiological
F, Gruenheid S, Ponka P, Gros P, submitted manuscript]signaling molecule. Heme oxygenase-2 is selectively ex-
to contain high levels of Nramp2, a putative iron trans-pressed in epithelial cells of the thick ascending limbs
porter (Figure 1), suggesting an active iron metabolismand distal convoluted tubule, connecting tubule cells,
in this organ. However, since Nramp2 is also involvedand principal cells of the collecting duct [58]. Heme oxy-
in the transport of numerous divalent metals [30], thegenase-1 is inducible by heme and a large number of
high expression of Nramp2 in the kidney may be relatedstructurally unrelated chemicals and various forms of
to the transport of not only iron but also other metals.cellular stress [9, 10]. Hence, it is not totally surprising
that ischemia/reperfusion, a well-established model of
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